Real-time enrollment status for this non-proliferative diabetic retinopathy clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:42 AM UTC
| NCT Number | NCT07235085 |
| Recruiting Status | Recruiting |
| Condition | Non-Proliferative Diabetic Retinopathy |
| Phase | PHASE3 |
| Target Enrollment | 930 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ocular Therapeutix, Inc. |
| Last Updated on CT.gov | March 16, 2026 (Mar 16, 2026) |
As of July 18, 2026: Clinical trial NCT07235085 is currently recruiting participants. This phase3 study for non-proliferative diabetic retinopathy is actively seeking new participants at 1 location across the United States. The study is sponsored by Ocular Therapeutix, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07235085 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07235085 was last updated Mar 16, 2026 (March 16, 2026). HelloStudys verifies this status automatically.